Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oligomet-DK. National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients

NCT04086290 is registered in ClinicalTrials.gov with Peter Busch Østergren as lead sponsor.

NCT NCT04086290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04086290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oligomet-DK. National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
Lead sponsor
Peter Busch Østergren
Phase
Phase 1/2
Overall status
Recruiting
Start date
October 10, 2019
Completion date
October 31, 2028
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer metastatic